Bladder cancer Clinical Trials
Recruiting bladder cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat bladder cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting bladder cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting bladder cancer trials
Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)
Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients
The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer
Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)
SL-28 for Advanced Solid Tumours
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
Prehabilitation in High-risk Oncologic Surgery
DBC-664 in Adult Patients With Solid Tumors Associated
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer
Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial
Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
A Study of GEN1106 in Participants With Solid Tumors
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer
Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Cancer Loyalty Card Study 2 (CLOCS-2)
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Circulating Tumor DNA Response In Urothelial Cancer
Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11)
Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration
Validity of Parametric MRI Using VIRADS
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Patients: A Randomized Controlled Trial and Observational Study
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Bladder cancer clinical trials — common questions
Are bladder cancer clinical trials free to join?
Yes. Participating in a bladder cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a bladder cancer clinical trial?
Each bladder cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a bladder cancer trial near me?
Use the location controls above. We'll show recruiting bladder cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many bladder cancer trials are recruiting right now?
We're currently tracking roughly 139 recruiting bladder cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.